CFDE Data Portal | Search GUSBP9

	Label	Description
	GUSBP9 associations Collection (Entity type)	Associations for GUSBP9_associations
	GUSBP9 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GUSBP9 Gene (Entity type)	ENSG00000215630 - GUSB pseudogene 9
	GSE146358 dopamine 3 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE199538 GSE199539 enzalutamide 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE130246 enzalutamide UM 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE258991 enzalutamide DK1 [Tursiops] 5 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE130246 enzalutamide UM 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE128255 NDP knockdown stem cell 3 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE149049 FLT3 inhibition 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS

GUSBP9 associations

Associations for GUSBP9_associations

GUSBP9 associations.tsv

A file from IDG as part of the Harmonizome project

GUSBP9

ENSG00000215630 - GUSB pseudogene 9

GSE146358 dopamine 3 v 7 human dn

A Gene Set from LINCS

GSE199538 GSE199539 enzalutamide 2 v 1 human dn

A Gene Set from LINCS

GSE130246 enzalutamide UM 1 v 3 human dn

A Gene Set from LINCS

GSE258991 enzalutamide DK1 [Tursiops] 5 v 0 human up

A Gene Set from LINCS

GSE130246 enzalutamide UM 1 v 0 human dn

A Gene Set from LINCS

GSE128255 NDP knockdown stem cell 3 v 0 human up

A Gene Set from LINCS

GSE149049 FLT3 inhibition 1 v 2 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.